Published in the Commonwealth of Australia Gazette, No GN 27, 15 July 2009
THERAPEUTIC GOODS ACT 1989
I, PETER BIRD, Acting Head - Office of Non-Prescription Medicines, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing for the purposes of Section 42DF(1) of the Therapeutic Goods Act 1989, give notice that the restricted representation described in paragraph (a), has been approved for use in advertisements directed to consumers, for the product listed in paragraph (b) below:
- Representations to the effect that advertisements to consumers for the goods described in paragraph (b) may refer to:
- "to provide effective relief of ear pain associated with Otitis Media"
- Auralgan Ear Drops (AUST R 10460)
sponsored by Wyeth Consumer Healthcare Pty Ltd.
Dated this 6th day of July 2009
Peter Bird
Delegate of the Secretary to the Department of Health and Ageing